enVVeno Medical

enVVeno Medical Corporation is a clinical-stage medical device company based in Irvine, California. Founded in 1987, the company focuses on developing bioprosthetic tissue-based solutions for treating venous diseases, particularly severe Chronic Venous Insufficiency (CVI). enVVeno aims to meet significant medical needs in vascular medicine by restoring proper venous function. The company's primary product is the VenoValve, a surgically implanted replacement venous valve designed to restore blood flow from the leg to the heart. This device is currently in late-stage clinical development and undergoing pivotal trials, including the SAVVE trial in the United States. Additionally, enVVeno is developing the enVVe, a non-surgical, transcatheter-based valve system that offers a less invasive treatment option for venous valve replacement. enVVeno Medical is dedicated to advancing care standards in venous disease, with a focus on improving patient outcomes and quality of life. The company collaborates with vascular surgeons and interventional specialists to provide innovative solutions for patients suffering from CVI.

• Employees 37
• Founded 1999
• Annual Revenue $31000
• Total Funding $25554000